Perinatal transmission and cure of extensively drug-resistant tuberculosis in an infant
- PMID: 41058924
- PMCID: PMC12500178
- DOI: 10.7196/AJTCCM.2025.v31i2.2346
Perinatal transmission and cure of extensively drug-resistant tuberculosis in an infant
Abstract
We describe a rare case of perinatally acquired extensively drug-resistant tuberculosis in an infant. The infant was successfully treated with an individualised all-oral multidrug regimen containing delamanid, a drug rarely described in the treatment of perinatal tuberculosis. What the study adds. This brief report offers insight into a clinical case of perinatally acquired extensively drug-resistant tuberculosis (XDR-TB), and outlines the individualised treatment plan that led to a successful treatment outcome. Implications of the findings. The report highlights the need for evidence-based guidance on XDR-TB in this paediatric population, as well as further research on preventive strategies for mitigating mother-to-child transmission of TB.
Keywords: Drug-resistant tuberculosis; perinatal tuberculosis.
Copyright © 2025, Author(s).
References
-
- World Health Organization. Geneva: WHO; 2023. [10 June 2024]. Global tuberculosis report 2023.https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-heal...
-
- World Health Organization. Geneva: WHO; 2020. [10 June 2024]. Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis. 27-29 October 2020. .https://www.who.int/publications/i/item/9789240018662
-
- Shenoi A, Kavitha A. Perinatal tuberculosis. Pediatr Infect Dis. 2019;1(1):30–33. doi: 10.5005/jp-journals-10081-1107. - DOI
LinkOut - more resources
Full Text Sources